TY - JOUR
AU - Kumar B
AU - Thakur V
AU - Narang T
AU - Dogra S
AB - We read with interest the viewpoint by Lockwood and colleagues on the recent World Health Organization (WHO) guidelines recommending three drugs for treating paucibacillary (PB) leprosy. Out of the various other issues raised by the authors (namely, diagnostic tests, reactions, stigma, and disability), we would like to submit our perception only on the issue of addition of clofazimine to this recommended therapeutic regimen.
BT - PLoS neglected tropical diseases
C1 - https://www.ncbi.nlm.nih.gov/pubmed/32497033
DA - 06/2020
DO - 10.1371/journal.pntd.0008169
IS - 6
J2 - PLoS Negl Trop Dis
LA - eng
N2 - We read with interest the viewpoint by Lockwood and colleagues on the recent World Health Organization (WHO) guidelines recommending three drugs for treating paucibacillary (PB) leprosy. Out of the various other issues raised by the authors (namely, diagnostic tests, reactions, stigma, and disability), we would like to submit our perception only on the issue of addition of clofazimine to this recommended therapeutic regimen.
PY - 2020
EP - e0008169
T2 - PLoS neglected tropical diseases
TI - Response to "Three drugs are unnecessary for treating paucibacillary leprosy-A critique of the WHO guidelines".
UR - https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0008169&type=printable
VL - 14
SN - 1935-2735
ER -